Evfm earnings outlook
WebThe Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Evofem Biosciences Inc’s P/E ratio is 0.00. Web1 day ago · Look out for EVFM's next earnings release expected on March 02, 2024. For the next earning release, we expect the company to report earnings of -$0.15 per share, reflecting a year-over-year ...
Evfm earnings outlook
Did you know?
WebView the latest Evofem Biosciences Inc. (EVFM) stock price, news, historical charts, analyst ratings and financial information from WSJ. WebApr 6, 2024 · Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q2 2024 Results - Earnings Call Transcript. SA Transcripts Wed, Aug. 11, 2024.
WebView all EVFM assets, cash, debt, liabilities, shareholder equity and investments. ... 1:40p Barron's Smucker Rises on Earnings, Boost to Full-Year Outlook 1:38p Dow attempts to bounce back ... WebJun 4, 2024 · NasdaqCM:EVFM Earnings and Revenue Growth June 4th 2024. We like that insiders have been buying shares in the last twelve months. Having said that, most people consider earnings and revenue growth ...
WebApr 6, 2024 · Evofem Biosciences, Inc. (EVFM) consensus earnings estimates: forecast for revenue and EPS, high & low, YoY growth, forward PE and number of analysts. Web1 day ago · Look out for EVFM's next earnings release expected on March 02, 2024. For the next earning release, we expect the company to report earnings of -$0.15 per share, …
WebApr 10, 2024 · Analyst Forecast. According to 7 analysts, the average rating for EVFM stock is "Buy." The 12-month stock price forecast is $1.84, which is an increase of 2,692.11% from the latest price.
WebPerformance Outlook. Short Term. 2W - 6W. Mid Term. 6W - 9M ... based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. ... EVFM) today announced a major new win in ... scg advisory \\u0026 corporate services sdn bhdWebEvofem Biosciences Inc's (NASDAQ: EVFM) Q2 Phexxi sales increased 42% Y/Y to $6.0 million, reflecting higher ex-factory sales and lower gross-to-net adjustments of 40%. The … rush 25 rucksackWebAug 11, 2024 · Shares of Evofem Biosciences (NASDAQ:EVFM) decreased 2.7% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per … rush 28cpvxWebApr 12, 2024 · Evofem Biosciences Inc’s trailing 12-month revenue is $20.2 million with a -589.0% profit margin. Year-over-year quarterly sales growth most recently was 276.5%. Analysts expect adjusted earnings to reach $-7.960 per share for the current fiscal year. Evofem Biosciences Inc does not currently pay a dividend. The outlook for the ... rush 2cWebIn fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns … rush 2 carsWebMay 04, 2024. $2.47. $1.66. -32.79%. Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings … rush 2 arcadeWebThe page provides an overview of the company's financial health, with key data points such as the current stock price, earnings per share, and revenue compared against the forecast. Earnings Insights rush 2 cast